6,8-disubstituted-9-(heterocyclyl) purines, compositions containing these derivatives and their use in cosmetic and medicinal applications
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F19%3A73596523" target="_blank" >RIV/61989592:15110/19:73596523 - isvavai.cz</a>
Alternative codes found
RIV/61389030:_____/19:00509665 RIV/61989592:15310/19:73596523
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=EP&NR=3233861B1&KC=B1&FT=D&ND=4&date=20190410&DB=&locale=en_EP" target="_blank" >https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=EP&NR=3233861B1&KC=B1&FT=D&ND=4&date=20190410&DB=&locale=en_EP</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
6,8-disubstituted-9-(heterocyclyl) purines, compositions containing these derivatives and their use in cosmetic and medicinal applications
Original language description
The invention relates to 6,8-disubstituted-9-(heterocyclyl) purines, compositions containing these derivatives and their use in cosmetic and medicinal applications.6,8-Disubstituted-9-(heterocyclyl)purines for use in pharmaceutical and cosmetic compositions and applications are provided. These 6,8-disubstituted-9-(heterocyclyl)purines have a wide range of biological activities, including for example antioxidant, anti-inflammatory, anti-senescent, anti-aging, as well as well as other activities which are especially useful in pharmaceutical and cosmetic applications. Compositions may include additional excipients and auxiliary substances. Methods of treatment of animals, mammals, plants, cells, yeast, and cells in tissue culture are also disclosed.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2019
Confidentiality
C - Předmět řešení projektu podléhá obchodnímu tajemství (§ 504 Občanského zákoníku), ale název projektu, cíle projektu a u ukončeného nebo zastaveného projektu zhodnocení výsledku řešení projektu (údaje P03, P04, P15, P19, P29, PN8) dodané do CEP, jsou upraveny tak, aby byly zveřejnitelné.
Data specific for result type
Patent/design ID
EP3233861
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Apr 10, 2019
Owner name
Ústav experimentální botaniky AV ČR v.v.i., Univerzita Palackého v Olomouci
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence